Black Bird Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 23, 2022 at 08:07 am
Share
Black Bird Biotech, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.030943 million compared to USD 0.033005 million a year ago. Net loss was USD 0.522594 million compared to USD 0.265814 million a year ago.
For the six months, sales was USD 0.044745 million compared to USD 0.035212 million a year ago. Net loss was USD 1.19 million compared to USD 0.474047 million a year ago.
Black Bird Biotech, Inc. is a manufacturer and distributor for MiteXstream, an environmental protection agency (EPA)-certified plant-based biopesticide effective in the eradication of mites and other similar pests, including spider mites, that destroy crops, particularly cannabis, hops, coffee and house plants, as well as molds and mildew. The Company also manufactures and sells, under its Grizzly Creek Naturals brand name, cannabidiol (CBD) products, including CBD Oils, gummies and pet treats, as well as CBD-infused personal care products. Big Sky American Dist., LLC (Big Sky American) distributes its Grizzly Creek Naturals products, as well as an array of other consumer retail products, in Western Montana. The Company's subsidiaries include Black Bird Potentials Inc. (BB Potentials), Big Sky American Dist., LLC (Big Sky American) and Black Bird Hemp Manager, LLC.
BLACK BIRD BIOTECH, INC. 